Trial · NCT05643794
Participant flow45
How many started, completed or left each group, period by period.
21 to 40 of 45
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 2 (12 Weeks) | STARTED | Sequence 3: PBO + PBO | 20 | |
| Treatment Period 2 (12 Weeks) | COMPLETED | Sequence 1: RLZ 12w + RLZ 12w | 17 | |
| Treatment Period 2 (12 Weeks) | COMPLETED | Sequence 2: PBO + RLZ 12w | 18 | |
| Treatment Period 2 (12 Weeks) | COMPLETED | Sequence 3: PBO + PBO | 20 | |
| Treatment Period 2 (12 Weeks) | NOT COMPLETED | Sequence 1: RLZ 12w + RLZ 12w | 2 | |
| Treatment Period 2 (12 Weeks) | NOT COMPLETED | Sequence 2: PBO + RLZ 12w | 1 | |
| Treatment Period 2 (12 Weeks) | NOT COMPLETED | Sequence 3: PBO + PBO | 0 | |
| Run-Out Period (2 Weeks) | STARTED | Sequence 1: RLZ 12w + RLZ 12w | 17 | |
| Run-Out Period (2 Weeks) | STARTED | Sequence 2: PBO + RLZ 12w | 18 | |
| Run-Out Period (2 Weeks) | STARTED | Sequence 3: PBO + PBO | 20 | |
| Run-Out Period (2 Weeks) | COMPLETED | Sequence 1: RLZ 12w + RLZ 12w | 17 | |
| Run-Out Period (2 Weeks) | COMPLETED | Sequence 2: PBO + RLZ 12w | 18 | |
| Run-Out Period (2 Weeks) | COMPLETED | Sequence 3: PBO + PBO | 20 | |
| Run-Out Period (2 Weeks) | NOT COMPLETED | Sequence 1: RLZ 12w + RLZ 12w | 0 | |
| Run-Out Period (2 Weeks) | NOT COMPLETED | Sequence 2: PBO + RLZ 12w | 0 | |
| Run-Out Period (2 Weeks) | NOT COMPLETED | Sequence 3: PBO + PBO | 0 | |
| Safety Follow-up Period (5 Weeks) | STARTED | Sequence 1: RLZ 12w + RLZ 12w | 22 | |
| Safety Follow-up Period (5 Weeks) | STARTED | Sequence 2: PBO + RLZ 12w | 20 | |
| Safety Follow-up Period (5 Weeks) | STARTED | Sequence 3: PBO + PBO | 21 | |
| Safety Follow-up Period (5 Weeks) | COMPLETED | Sequence 1: RLZ 12w + RLZ 12w | 22 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05643794/flow?page=2